癌の誘発因子を明らかにするための統合的アプローチ
Uri David Akavia1, Oren Litvin, Jessica Kim
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Cell
|December 7, 2010
まとめ
この研究は,コピー番号と遺伝子発現データを統合することによって,がんを誘発する遺伝的変異を特定するためのコンピューティングフレームワークを導入しています. このアプローチは,メラノーマの主要な要因を正確に特定し,新しい依存性を明らかにし,新しい治療目標を示唆しました.
科学分野:
- ゲノミクスゲノミクスとは
- コンピュータ生物学 コンピュータ生物学
- がん研究 がん研究
背景:
- 癌ゲノムには,機能的意義がはっきりしない多様な遺伝的逸脱がある.
- 腫瘍の進行の主要な要因を特定することは,治療の開発に不可欠です.
研究 の 目的:
- 癌を誘発する遺伝子異常を検出するためのコンピューティング・フレームワークを開発し,検証する.
- メラノーマにおける新たな腫瘍依存性と潜在的な治療標的を特定する.
主な方法:
- 染色体複製数と遺伝子発現データの統合分析.
- ベイジアンアプローチを用いたコンピューティング・フレームワークの適用.
- 予測された腫瘍依存性の経験的検証.
主要な成果:
- このフレームワークは,既知のメラノーマの誘発因子を成功裏に特定しました.
- 2つの新しい腫瘍依存性:TBC1D16とRAB27A.を予測し,実証的に確認しました.
- メラノーマの増殖におけるタンパク質密輸の制御不全の役割を強調した.
結論:
- 統合的コンピューティングのアプローチは,生物学的に重要な癌の要因を効果的に特定することができます.
- 特定された依存性であるTBC1D16およびRAB27Aは,メラノーマにおける潜在的な治療標的を代表しています.
- 異常なタンパク質の密輸は,メラノーマの進行に関与しています.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870


